alprazolam has been researched along with Body Weight in 12 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Alprazolam, Scopolamine and high fat diet (HFD) induced amnesia served as interoceptive memory models where as, Water-maze and Elevated plus-maze served as exteroceptive models." | 3.74 | Reversal of memory deficits by Atorvastatin and Simvastatin in rats. ( Parle, M; Singh, N, 2007) |
| " Alprazolam's pharmacokinetics may be altered by age and sex, body weight, and concurrent treatment with cimetidine." | 3.66 | Pharmacokinetics of alprazolam. ( Abernethy, DR; Divoll, M; Greenblatt, DJ; Shader, RI, 1983) |
| "Alprazolam was administered orally ten days before mating and during the gestational period." | 1.91 | Alterations in the dentate gyrus of the offspring of rats treated with alprazolam during gestation. ( Mascarenhas, FNADP; Ribeiro, DL; Silva, NF; Zanon, RG, 2023) |
| "Treatment with alprazolam reversed the adverse effects of stress." | 1.36 | Inhibitory effects of alprazolam on the development of acute experimental autoimmune encephalomyelitis in stressed rats. ( Almeida-Dias, A; Freire-Garabal, M; Novío, S; Núñez-Iglesias, MJ, 2010) |
| "Treatment with alprazolam (0." | 1.35 | Protective effect of alprazolam against sleep deprivation-induced behavior alterations and oxidative damage in mice. ( Kumar, A; Singh, A, 2008) |
| " Previous studies revealed that chronic administration of the anxiolytic alprazolam reduced indices of CRF and CRF1 receptor function." | 1.32 | Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression. ( Nemeroff, CB; Owens, MJ; Skelton, KH, 2004) |
| "NONMEM was applied to single dose and multiple dose bioavailability data for an immediate release (IR) and a controlled release (CR) dosage form of alprazolam to acquire additional information from the data which are not easily obtainable by traditional means." | 1.30 | Nonlinear mixed effects modeling of single dose and multiple dose data for an immediate release (IR) and a controlled release (CR) dosage form of alprazolam. ( Baweja, R; Hossain, M; Ludden, T; Miller, R; Wright, E, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Silva, NF | 1 |
| Mascarenhas, FNADP | 1 |
| Ribeiro, DL | 1 |
| Zanon, RG | 1 |
| Pallier, PN | 1 |
| Morton, AJ | 1 |
| Huemer, HP | 1 |
| Lassnig, C | 1 |
| Nowotny, N | 1 |
| Irschick, EU | 1 |
| Kitchen, M | 1 |
| Pavlic, M | 1 |
| Núñez-Iglesias, MJ | 1 |
| Novío, S | 1 |
| Almeida-Dias, A | 1 |
| Freire-Garabal, M | 1 |
| Skelton, KH | 1 |
| Nemeroff, CB | 1 |
| Owens, MJ | 1 |
| Parle, M | 1 |
| Singh, N | 1 |
| Singh, A | 1 |
| Kumar, A | 1 |
| Abernethy, DR | 1 |
| Greenblatt, DJ | 1 |
| Divoll, M | 1 |
| Shader, RI | 1 |
| Hossain, M | 1 |
| Wright, E | 1 |
| Baweja, R | 1 |
| Ludden, T | 1 |
| Miller, R | 1 |
| Tapp, WN | 1 |
| Natelson, BH | 1 |
| Creighton, D | 1 |
| Khazam, C | 1 |
| Ottenweller, JE | 1 |
| O'Connor, WT | 1 |
| Earley, B | 1 |
| Leonard, BE | 1 |
| Greenberg, DB | 1 |
| Stern, TA | 1 |
| Weilburg, JB | 1 |
12 other studies available for alprazolam and Body Weight
| Article | Year |
|---|---|
Alterations in the dentate gyrus of the offspring of rats treated with alprazolam during gestation.
Topics: Alprazolam; Animals; Body Weight; Cell Proliferation; Cell Size; Dentate Gyrus; Female; Lipid Peroxi | 2023 |
Management of sleep/wake cycles improves cognitive function in a transgenic mouse model of Huntington's disease.
Topics: Affect; Alprazolam; Animals; Benzhydryl Compounds; Body Weight; Central Nervous System Stimulants; C | 2009 |
Diazepam leads to enhanced severity of orthopoxvirus infection and immune suppression.
Topics: Alprazolam; Animals; Antibodies, Viral; Antibody Formation; Apoptosis; Body Weight; Cell Proliferati | 2010 |
Inhibitory effects of alprazolam on the development of acute experimental autoimmune encephalomyelitis in stressed rats.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Body Weight; Corticosterone; Encephalomyelitis, Autoimmune | 2010 |
Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression.
Topics: Adrenocorticotropic Hormone; Alprazolam; Animals; Anti-Anxiety Agents; Autoradiography; Body Weight; | 2004 |
Reversal of memory deficits by Atorvastatin and Simvastatin in rats.
Topics: Alprazolam; Amnesia; Animals; Atorvastatin; Body Weight; Cholesterol; Dietary Fats; Female; Heptanoi | 2007 |
Protective effect of alprazolam against sleep deprivation-induced behavior alterations and oxidative damage in mice.
Topics: Alprazolam; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Behavioral Symptoms; Body Weig | 2008 |
Pharmacokinetics of alprazolam.
Topics: Age Factors; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Biotransformation; Body Weight; Cimet | 1983 |
Nonlinear mixed effects modeling of single dose and multiple dose data for an immediate release (IR) and a controlled release (CR) dosage form of alprazolam.
Topics: Adult; Age Factors; Alprazolam; Biological Availability; Body Weight; Delayed-Action Preparations; F | 1997 |
Alprazolam reduces stress-induced mortality in cardiomyopathic hamsters.
Topics: Alprazolam; Animals; Body Fluids; Body Temperature; Body Weight; Cardiomyopathies; Cricetinae; Organ | 1989 |
Antidepressant properties of the triazolobenzodiazepines alprazolam and adinazolam: studies on the olfactory bulbectomized rat model of depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Biogenic Amines; B | 1985 |
Fear of choking.
Topics: Adult; Airway Obstruction; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Body Weight; Fear; Feed | 1986 |